0.00Open0.01Pre Close0 Volume137 Open Interest85.00Strike Price0.00Turnover975.76%IV8.89%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0139Delta0.0172Gamma7807.00Leverage Ratio-13.0763Theta0.0000Rho108.68Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet